Authors: Page, DL Gray, R Allred, CC Dressler, LG Hatfield, AK Martino, S Robert, NJ Wood, WC

Citation: Dl. Page et al., Prediction of node-negative breast cancer outcome by histologic grading and S-phase analysis by flow cytometry - An Eastern Cooperative Oncology Group study (2192), AM J CL ONC, 24(1), 2001, pp. 10-18

Authors: Simpson, JF Gray, R Dressler, LG Cobau, CD Falkson, CI Gilchrist, KW Pandya, KJ Page, DL Robert, NJ

Citation: Jf. Simpson et al., Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: Results from the Eastern Cooperative Oncology Group companion study, EST 4189, J CL ONCOL, 18(10), 2000, pp. 2059-2069

Authors: Saphner, T Weller, EA Tormey, DC Pandya, KJ Falkson, CI Stewart, J Robert, NJ

Citation: T. Saphner et al., 21-day oral etoposide for metastatic breast cancer - A phase II study and review of the literature, AM J CL ONC, 23(3), 2000, pp. 258-262

Authors: Robert, NJ

Citation: Nj. Robert, Role of postmastectomy radiotherapy: A medical oncology perspective, SEM RAD ONC, 9(3), 1999, pp. 241-246

Authors: Cobleigh, MA Vogel, CL Tripathy, D Robert, NJ Scholl, S Fehrenbacher, L Wolter, JM Paton, V Shak, S Lieberman, G Slamon, DJ

Citation: Ma. Cobleigh et al., Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease, J CL ONCOL, 17(9), 1999, pp. 2639-2648

Authors: Harris, JR Halpin-Murphy, P McNeese, M Mendenhall, NP Morrow, M Robert, NJ

Citation: Jr. Harris et al., Consensus statement on postmastectomy radiation therapy, INT J RAD O, 44(5), 1999, pp. 989-990